tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ab&B Bio-Tech CO., LTD. Seeks Full Circulation of H Shares

Story Highlights
  • Ab&B Bio-Tech CO., LTD. applies to convert 81,661,895 unlisted shares into H shares.
  • The conversion aims to enhance market presence and liquidity, pending regulatory approvals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ab&B Bio-Tech CO., LTD. Seeks Full Circulation of H Shares

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) just unveiled an announcement.

Ab&B Bio-Tech CO., LTD. has announced its application to the China Securities Regulatory Commission for the conversion of 81,661,895 unlisted shares into H shares, which will be listed on the Main Board of The Stock Exchange of Hong Kong Limited. This move is part of the company’s strategy to enhance its market presence and liquidity, subject to regulatory approvals, and reflects a significant step in aligning with the guidelines for full circulation of shares.

More about Ab&B Bio-Tech CO., LTD. JS Class H

Ab&B Bio-Tech CO., LTD. is a joint stock company established in the People’s Republic of China, operating within the biotechnology sector. The company focuses on the development and commercialization of biotech products and services, with a market presence that includes the listing of its H shares on The Stock Exchange of Hong Kong Limited.

Average Trading Volume: 833,059

Learn more about 2627 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1